Aeon Global Health Corp (fka AGHC)

[Tracker7]

What are you indicating with your response?

[threewheeler]

AGHC SECURITY DETAILS
Share Structure
Market Cap Market Cap
500,711
10/28/2020
Authorized Shares
190,000,000
10/28/2020
Outstanding Shares
9,915,064
10/28/2020
Restricted
4,913,057
10/28/2020
Unrestricted
5,002,007
10/28/2020
Held at DTC
4,631,693
10/28/2020

[Tracker7]

Finally a little bit of positive news. AEON performing COVID testing.

https://aeonglobalhealth.com/

[StockingStuffer1000]

FDA granted EUA for company's covid testing
https://www.fda.gov/media/142532/download

[Tracker7]

Hmmm...so what does this mean for investors?

[lucky, mydog]

https://www.sec.gov/litigation/admin/2020/34-90003.pdf

[Maddog 112]

If a contract is coming volume should pick up

[Golden Cross]

Looks like it bottomed here for a move

[Maddog 112]

Hay golden cross I got some news today that AGHC may be getting a piece of covid through a sizeable contract in testing for covid 19 since HAON is a large laboratory testing facility , contract could be in the millions. AGHC is a very low float stock and with news could run in the dollars like nothing. Possible looking to add 1 to 2k just in case this week

[Maddog 112]

I'm sorry Aeon is located in Georgia and don't you think its odd that 60k shares were traded with a stop sign, thinking when this is removed and filings come in sometime could b happening here soon. I have been waiting years and only 9.9 million o/s and super low float I can't imagine what will happen if we can get a buying spree. Last I know AEON quarterly earnings were in the millions

[Golden Cross]

That would be interesting...

[Maddog 112]

My buy showed up red thinking a thousand could turn to 10k real fast here , my stock broker is very knowledgeable on this stock and actually visited the company to take a better look, I'll give him a call Monday and see if I can get some information

[Golden Cross]

Yes, nice volume and mostly buys I see...$AGHC

[Maddog 112]

Had a small order at .05 and only a third got filled ,this is the most shares traded today that I've seen in a long time maybe something going on here soon

[Maddog 112]

Is that good they dropped a tier

[Golden Cross]

Hello, just noticed the tier change this morning on it... will be DDing it some this weekend...Thanks for the background info...GL $AGHC

[Maddog 112]

Hello golden cross surprised to see you here or anyone for that matter,I'm very familiar with this stock for at least 10 yrs it was a small company that had great technology in the medical field and lost a huge contract to the veterans hospitals throughout the country and the stock tanked. Finally they were merging with a big laboratory company out of Carolinas making .millions with high Hope's of becoming big again and the stock sank to an all time low so not sure if or when this will move again butI know it moves with ease any buying and this will b a dollar in days .

[Golden Cross]

$AGHC Tier_Change: OTCQB to Pink Limited

OTCM Link
https://www.otcmarkets.com/stock/AGHC/disclosure

[Tracker7]

https://www.watchlistnews.com/aeon-global-health-aghc-upgraded-to-hold-at-zacks-investment-research/2748782.html

[Tracker7]

Anyone receive a Proxy Vote invitation for Dec 6? If so, what insight do you have about the different proposals?

[Tracker7]

New 10K report finally.

https://www.sec.gov/Archives/edgar/data/885074/000143774918017443/aghc20180630_10k.htm

[Tracker7]

Hopefully AGHC gets their act together and gets a part of this.

https://businessanalyst24.com/312852/toxicology-laboratories-market-is-set-to-garner-staggering-revenues-by-2026/

[tbirddan]

Not very good at investor relations yet! LOL

[Tracker7]

Looks like their ER is late. Sent them 3 emails with no response.

[tbirddan]

That would be nice and a welcome change.

[Tracker7]

Hmmm...AGHC website has a new look. Hopefully some kind of good news on its way.

[Renee]

ADAT: effective Feb. 1,2018 Authentidate Holding Corp., ADAT, will change to Aeon Global Health Corp., AGHC:

http://otce.finra.org/DLSymbolNameChanges

[willlbone]

Quess the 10Q sucked.

[judypudy]

Noticed ADAT has a OTC Market Verified Share Structure. Anyone here know why Held at DTC is larger than float? TIA
http://www.otcmarkets.com/stock/ADAT/profile

[Tracker7]

With ADAT new COO and CFO, they are set up to launch their new strategic plans.

[Tracker7]

http://www.prnewswire.com/news-releases/aeon-global-health-operating-arm-of-authentidate-holding-corp-names-david-c-goldberg-as-its-new-chief-operating-officer-300516987.html

[Tracker7]

http://www.prnewswire.com/news-releases/aeon-global-health-names-michael-j-poelking-as-chief-financial-officer-and-treasurer-300518830.html

[Tracker7]

http://www.prnewswire.com/news-releases/aeon-global-health-operating-arm-of-authentidate-holding-corp-names-david-c-goldberg-as-its-new-chief-operating-officer-300516987.html

[ok2aBuB]

Aeon Global Health, Operating Arm of Authentidate Holding Corp., Names David C. Goldberg as its new Chief Operating Officer.

[Tracker7]

http://www.prnewswire.com/news-releases/authentidate-holding-corp-announces-uplisting-to-the-otcqb-tier-300505636.html

[shilverbug91]

ADAT $$$$$

[shilverbug91]

Looks like Authentidate's ready to turn the corner ;) Will be keeping a very close eye on this one.. they're current now!

ADAT $$$$$

[236T568]

Item 4.01 Changes in Registrant’s Certifying Accountant.

(a) Dismissal of EisnerAmper, LLP

On April 20, 2017, Authentidate Holding Corp. (the “ Company ”) dismissed EisnerAmper, LLP (“ Eisner ”) as the Company’s independent registered public accounting firm. Eisner has served as the Company’s independent registered public accounting firm since April 2005. The decision to dismiss Eisner as the Company’s independent registered public accounting firm was approved by the Audit Committee of the Board of Directors. The reports of Eisner on the Company’s financial statements for each of the full fiscal years ended June 30, 2016 and June 30, 2015 did not contain an adverse opinion or a disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles, except that Eisner’s reports for both periods included an explanatory paragraph expressing the substantial doubt about the Company’s ability to continue as a going concern. The conclusion of Eisner that the Company may be unable to continue as a going concern was based on its negative working capital position and that its capital requirements have been and will continue to be significant.

During the Company’s fiscal years ended June 30, 2016 and June 30, 2015, and through the date of dismissal, there were no disagreements with Eisner on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure which, if not resolved to the satisfaction of Eisner, would have caused Eisner to make reference to the subject matter of the disagreement in connection with its report. Further, during the fiscal years ended June 30, 2016 and June 30, 2015 and the subsequent period through the date of dismissal, there have been no reportable events within the meaning of Item 304(a)(1)(v) of Regulation S-K promulgated by the Securities and Exchange Commission (the “ SEC ”), except as described herein.

In connection with its review of the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2016, the audit of the Company’s financial statements included in the Company’s Transition Report on Form10-KT for the six month period ended June 30, 2015, and the audit of the Company’s financial statements included in its Annual Report on Form 10-K for the fiscal year ended June 30, 2016, Eisner had advised the Company of certain material weaknesses in the Company’s system of internal control over financial reporting. In each of these periodic reports, the Company disclosed material weaknesses in its system of internal controls. These material weaknesses relate to insufficient resources in its accounting function; insufficient levels of monitoring, oversight and segregation of duties; inadequate controls to ensure that information necessary to properly record transactions is adequately communicated on a timely basis from non-financial personnel to those responsible for financial reporting; and the inability to establish and maintain effective controls over the identification of reduced revenue collections due to modifications of payor claims adjudication process and lack of communication between financial personnel and non-financial personnel which resulted in the overstatement of revenues and accounts receivable for the period ended March 31, 2016. Consistent with such findings, the Company’s management concluded that its internal control over financial reporting was not effective as of such periods. In addition, as previously reported by the Company, on February 17, 2017, the Audit Committee of the Board of Directors determined that the unaudited interim financial statements included in the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ending March 31, 2016, filed on September 27, 2016, contained material errors related to Company’s recognized revenue estimates and would be restated. The Company subsequently filed an amendment to its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2016 (the “ Amended Form 10-Q ”) to restate the financial statements contained therein on April 5, 2017. As described in the Amended Form 10-Q, the restatement was necessitated due to errors in the revenue estimates the Company employed for the quarter ended March 31, 2016, which did not account for changes in the claims adjudication processes utilized by payors beginning in January 2016 as well as the decision by the Centers for Medicare and Medicaid Services (CMS) in January 2016 to reduce the unit reimbursement rate for many of the tests typically performed by the Company along with the number of tests that CMS would reimburse. The Company had also concluded that these errors resulted from the material weaknesses in the Company’s internal control over financial reporting.

The Company provided Eisner with a copy of this Form 8-K, and requested that Eisner furnish it with a letter addressed to the SEC stating whether it agrees with the statements made by the Company in this Item 4.01, and, if not, stating the respects in which it does not agree. The letter of Eisner addressed to the SEC is attached hereto as Exhibit No. 16.1.




(b) Engagement of Rosenberg Rich Baker Berman & Company

Further, on April 18, 2017, the Audit Committee of the Company’s Board of Directors engaged Rosenberg Rich Baker Berman & Company (“ RRBB ”) as the Company’s independent registered public accounting firm for the 2017 fiscal year. Prior to the engagement of RRBB, neither the Company nor anyone acting on its behalf consulted with RRBB regarding (i) the application of accounting principles to a specific transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and neither a written report or oral advice was provided to the Company that RRBB concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing, or financial reporting issue; (ii) any matter that was the subject of a disagreement within the meaning of Item 304(a)(1)(iv) of Regulation S-K; or (iii) any reportable event within the meaning of Item 304(a)(1)(v) of Regulation S-K.

http://ih.advfn.com/p.php?pid=nmona&article=74406207&symbol=ADAT

[236T568]

ADAT exchanges $2.17 million notes due with notes that convert at $2.03 per share


https://www.sec.gov/Archives/edgar/data/885074/000114420417016559/v462573_8k.htm

Item 1.01 Entry into a Material Definitive Agreement.

On March 20, 2017, Authentidate Holding Corp. (the “Company”) entered into a note exchange agreement with the holders of an aggregate principal amount of $2,170,000 of outstanding promissory notes (the “Original Notes”) which were due and payable, pursuant to which the Company agreed to issue the holders of such notes, in consideration of the cancellation of the Original Notes, new promissory notes in the aggregate principal amount of $2,545,199, which is equal to the sum of the aggregate principal amount of the Original Notes plus the accrued but unpaid interest on the Original Notes (the “New Notes”). The New Notes are convertible into shares of the Company’s Common Stock at an initial conversion price of $2.03 per share. Based on the initial conversion price, the New Notes are convertible into up to 1,253,792 shares of common stock. If the Company issues or sells shares of its common stock, rights to purchase shares of its common stock, or securities convertible into shares of its common stock for a price per share that is less than the conversion price then in effect, such conversion price will be decreased to equal 85% of such lower price. The foregoing adjustments to the conversion price will not apply to certain exempt issuances, including issuances pursuant to certain employee benefit plans. In addition, the conversion price is subject to adjustment upon stock splits, reverse stock splits, and similar capital changes. The right of holders of the New Notes to convert these securities into common stock is subject to a 4.99% beneficial ownership limitation, which beneficial ownership limitation may be increased by a holder to a greater percentage not in excess of 9.99% after providing notice to us. The closing of the exchange transaction occurred on March 20, 2017 and all of the New Notes have a maturity date of one year from the closing date. The New Notes are being issued in consideration of the exchange of (i) an aggregate principal amount of $950,000 of Original Notes held by VER 83, LLC, which were convertible at a price of $2.25 per share, (ii) an aggregate principal amount of $520,000 of Original Notes, held by MKA 79, LLC, which were convertible at a price of $3.00 per share, and (iii) an aggregate principal amount of $700,000 of unconvertible Original Notes, of which a note in the principal amount of $250,000 was held by Hanif A. Roshan, the Chairman and Chief Executive Officer of the Company and the remainder was held by Optimum Ventures, LLC, a party affiliated by ownership with the former members of Peachstate Health Management, LLC, our subsidiary.

[in2it]

The jig may be up...

Since the 1st of the year there has been at least one director resigning with castigating claims of malfeasance, the removal of the CFO & COO, and a notice of financial instruments non-reliance and accounting errors. And not an informative peep from the company.

The employee stock incentive program...

[236T568]

Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.

https://www.sec.gov/Archives/edgar/data/885074/000114420417010384/v460133_8k.htm


Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.

(a) On February 17, 2017, the Audit Committee of the Board of Directors (the “Audit Committee”) of Authentidate Holding Corp. (the “Company”) determined that the unaudited interim financial statements included in the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ending March 31, 2016, filed on September 27, 2016, should no longer be relied upon and that the Company will be required to restate its previously-filed interim financial statements for the fiscal quarter ended March 31, 2016. The Audit Committee concluded that the unaudited interim financial statements of the Company for the three-month and nine-month periods ended March 31, 2016 contain material errors related to Company’s recognized revenue estimates. The Company intends to provide amended financial results for such periods as soon as practicable.

In recognizing revenue for its financial reports, the Company estimates and records revenue at the time test results are delivered, net of contractual allowances and adjustments. The revenue estimate employed for the quarter ended March 31, 2016 was 15.25% of total billings, based in large part on historical actuals. Beginning in calendar 2016, commercial and government payors, who comprise the major source of collections for the Company, focused on reducing payments to clinical laboratories by imposing more stringent payment guidelines in their adjudication processes. The impact of these changes was a reduction in revenues, thereby lowering actual collections. . Additionally, effective January 2016, the Centers for Medicare and Medicaid Services (CMS) reduced the unit reimbursement rate for many of the tests typically performed by the Company, along with the number of tests that CMS would reimburse. Because Medicare and Medicaid accounts for close to 50% of the Company’s annual revenue, this reduction in reimbursement rates had a substantial negative impact on the Company’s revenue. Management has determined that for the quarter ended March 31, 2016, the Company did not accurately account for these changes, resulting in the Company overstating its revenues and accounts receivable balance. Following management’s review of these matters, the Company has determined that its estimated collections rate for the quarter ended March 31, 2016 should have been approximately 10.41%, resulting in a decrease in revenues for the quarter of approximately $2,113,000.

The following summarizes the estimated effects of the restatement:

(1) total revenues for the third quarter of fiscal 2016 will decrease from $7,616,000 to $5,503,000 and total revenues for the nine-months ended March 31, 2016 will decrease from $30,214,000 to $28,101,000;

(2) operating income for the third quarter of fiscal 2016 will decrease from $851,000 to a loss of $1,262,000 and operating income for the nine-months ended March 31, 2016 will be reduced from $9,912,000 to $7,799,000; and

(3) the Company’s accounts receivable balance at March 31, 2016 will be reduced from $4,549,000, net, to $2,436,000, net, and retained earnings as of such date will decrease from $5,416,000 to $3,303,000.

The Company will file an amendment to its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2016 to reflect the restatement as soon as possible and thereafter intends to promptly file its Annual Report on Form 10-K for the fiscal year ended June 30, 2016 and Quarterly Reports on Form 10-Q for the subsequent fiscal quarters of fiscal 2017.

As previously reported in the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2016, management had determined that material weaknesses existed in the Company’s internal control over financial reporting at March 31, 2016. Management has concluded that the errors in accounting for the changes in the payor adjudication processes and the adjustment in CMS reimbursement rates resulted from the material weaknesses in the Company’s internal control over financial reporting. The Company will augment its plan to remediate the material weaknesses in its control structure to address the factors that resulted in the restatement. The Audit Committee and the Company’s executive management have discussed the matters described herein with the Company’s independent registered public accounting firm.

This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the current beliefs and expectations of Authentidate Holding Corp.’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. Factors that could cause the Company’s actual results to differ materially from those described in the forward-looking statements can be found in the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2015, which was filed with the Securities and Exchange Commission on February 22, 2016 and is available on the Securities and Exchange Commission’s website (www.sec.gov). Authentidate Holding Corp. does not undertake to update the forward-looking statements to reflect the impact of circumstances or events that may arise after the date of the forward-looking statements.

2


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

AUTHENTIDATE HOLDING CORP.


By: /s/ Hanif A. Roshan
Name: Hanif A. Roshan
Title: Chief Executive Officer

[236T568]

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 7, 2016, the employment of Richard Hersperger, Chief Executive Officer of Authentidate Holding Corp. (the “Company”), terminated. In connection therewith, the Company and Mr. Hersperger anticipate entering into a separation agreement. Mr. Hersperger will remain a member of the board of directors of the Company.

Hanif (“Sonny”) Roshan, the Company’s current Chairman, assumed the position of Chief Executive Officer on August 7, 2016. Mr. Roshan’s compensation will remain the same at this time. The information required by Item 401(b), (d) and (e) and Item 404(a) of Regulation S-K and Item 5.02(c)(3) of Form 8-K is disclosed in and incorporated herein by reference from the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 1, 2016.


http://ih.advfn.com/p.php?pid=nmona&article=72203177&symbol=ADAT

[236T568]

Our common stock is now quoted on the OTCQB, which could adversely affect the market price and liquidity of our common stock.

Our common stock is currently traded on The OTCQB Market under the symbol “ADAT”. Our common stock had been listed on The NASDAQ Capital Market until January 28, 2016, when it was suspended for failure to comply with The NASDAQ Capital Market continued listing standards. On January 29, 2016, our common stock began trading on the OTC Markets’ OTCQB market tier under the trading symbol “ADAT.” On January 27, 2016, the company received notification from The Nasdaq Stock Market LLC that trading in the company’s common stock would be suspended on Nasdaq effective with the open of business on Friday, January 29, 2016, due to the company’s continuing non-compliance with the stockholders’ equity requirement set forth in NASDAQ Listing Rule 5550(b)(1) and minimum bid price requirement in NASDAQ Listing Rule 5550(a)(2).

As previously reported, the Nasdaq Listing Qualifications Hearing Panel (the “Panel”) had issued a decision on September 16, 2015 and had determined to grant the request of the company to remain listed on The NASDAQ Stock Market, subject to the condition that, on or before January 25, 2016, the company would announce and inform the Panel that the proposed business combination transaction has closed and that NASDAQ’s Listing Qualifications Staff (the “Staff”) has approved an initial listing application for the resulting entity. As we did not complete the AEON transaction prior to January 25, 2016, NASDAQ issued a delisting notice to us on January 27, 2016. The company understands that its common stock will be formally delisted from Nasdaq via Nasdaq’s filing of a Form 25 “Notification of Delisting” with the Securities and Exchange Commission after all applicable appeal periods have lapsed.

Trading on the OTCQB Market is expected to reduce the market liquidity of our common stock. As a result, an investor may find it more difficult to dispose of, or obtain accurate quotations for the price of, our common stock and the price of our common stock could suffer a significant decline. Delisting may also impair our ability to raise capital. If our common stock trading price remains below $5.00 per share, trading in our common stock might also become subject to the requirements of certain rules promulgated under the Exchange Act, which require additional disclosure by broker-dealers in connection with any trade involving a stock defined as a “penny stock” (generally, any equity security not listed on a national securities exchange or quoted on Nasdaq that has a market price of less than $5.00 per share, subject to certain exceptions). Many brokerage firms are reluctant to recommend low-priced stocks to their clients. Moreover, various regulations and policies restrict the ability of shareholders to borrow against or “margin” low-priced stocks, and declines in the stock price below certain levels may trigger unexpected margin calls. Additionally, because brokers’ commissions on low-priced stocks generally represent a higher percentage of the stock price than commissions on higher priced stocks, the current price of the common stock can result in an individual shareholder paying transaction costs that represent a higher percentage of total share value than would be the case if our share price were higher. This factor may also limit the willingness of institutions to purchase our common stock. Finally, the additional burdens imposed upon broker-dealers by these requirements could discourage broker-dealers from facilitating trades in our common stock, which could severely limit the market liquidity of the stock and the ability of investors to trade our common stock.



https://www.sec.gov/Archives/edgar/data/885074/000119312516471686/d102937d10q.htm

[236T568]

FORM 25 - NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.


http://ih.advfn.com/p.php?pid=nmona&article=71053145&symbol=ADAT#PRIMARY_DOC_HTM_FOOTNOTE1

[En2style]

News!!!

Authentidate Holding Corp. Announces Reverse Stock Split

Source: GlobeNewswire Inc.
Common stock will begin trading on a split-adjusted basis on January 25, 2016


Authentidate Holding Corp. (Nasdaq:ADAT) today announced a 1-for-9 reverse split of its common stock. The reverse stock split will become effective at 5:00 p.m. Eastern Time today, January 22, 2016 and Authentidate’s common stock will begin trading on The NASDAQ Capital Market on a split-adjusted basis when the market opens on January 25, 2016.
The company’s board of directors will monitor market developments impacting its common stock and will consider a forward stock split in the future if circumstances warrant. The purpose of the reverse stock split is to ensure that the price of Authentidate’s common stock is increased to a level necessary for the company to meet the initial listing application criteria of NASDAQ. In accordance with these listing standards, we are required to have a minimum bid price of our common stock of at least $4.00 upon the completion of our pending transaction with Peachstate Health Management, LLC d/b/a AEON Clinical Laboratories (“AEON”). As described in our definitive proxy statement dated December 10, 2015, the failure to satisfy such minimum bid price requirements would subject the company to delisting from the NASDAQ Stock Market. There can be no assurance that the reverse stock split will have the desired effect of sufficiently raising the closing bid price of Authentidate’s common stock or that the NASDAQ Stock Market will otherwise approve the initial listing application.

The reverse stock split was approved by Authentidate’s stockholders at a special meeting held on January 20, 2016 and the board of directors was authorized to implement a reverse stock split and determine the ratio of the split within a range of not less than 1-for-2 or greater than 1-for-10. Thereafter, the board of directors determined to fix the ratio for the reverse stock split at 1-for-9. The common stock will continue to be reported on the NASDAQ Capital Market under the symbol “ADAT,” and the new CUSIP number for the company’s common stock following the reverse stock split is 052666302.

At this special meeting of stockholders, the company’s stockholders also approved an amendment to the certificate of incorporation to restrict certain transfers of our common stock that could result in an ownership change under Section 382 of the Internal Revenue Code and, therefore, materially inhibit the company’s ability to utilize its net operating losses under federal tax laws. As a result, the company’s shares of common stock will be subject to transfer restrictions such that holders of common stock are restricted from attempting to transfer shares of common stock to the extent that such transfer would either create or result in an individual or entity becoming a 4.9-percent shareholder of the common stock for purposes of Section 382 of the Internal Revenue Code of 1986, or increase the stock ownership percentage of any existing 4.9 percent shareholder.

At the effective time of the reverse stock split, every nine shares of Authentidate’s issued and outstanding common stock will be converted automatically into one issued and outstanding share of common stock, without any change in the par value per share. The reverse stock split will reduce the number of shares of Authentidate’s common stock outstanding as of the record date for the stockholders meeting from approximately 42.8 million to approximately 4.75 million. In addition, the reverse stock split will effect a proportionate adjustment to the per share exercise price and the number of shares issuable upon the exercise or settlement of all outstanding options and warrants to purchase or acquire shares of Authentidate’s common stock, and the number of shares reserved for issuance pursuant to Authentidate’s existing equity incentive compensation plans were reduced proportionately. The reverse split will also result in a proportionate adjustment to the conversion price and number of shares of common stock issuable upon the conversion of all outstanding shares of convertible preferred stock and underlying all outstanding convertible debt instruments. The number of authorized shares of the company’s common stock will not be affected by the reverse stock split.

No fractional shares will be issued as a result of the reverse stock split, and stockholders who otherwise would be entitled to a fractional share will receive, in lieu thereof, a cash payment based on the average closing sale price of shares of our common stock for the ten trading days immediately prior to the effective time of the reverse stock split as officially reported by NASDAQ. Authentidate’s transfer agent, Continental Stock Transfer & Trust Company, will provide instructions to stockholders of record regarding the process for exchanging shares.

Additional information regarding the reverse stock split and the transfer restrictions can be found in Authentidate’s definitive proxy statement filed with the Securities and Exchange Commission on December 10, 2015, copies of which are available at www.sec.gov or at www.authentidate.com under the SEC filings tab located on the Investor Relations page.

[Roy London]

ADAT bullish as it gets....weekly EMA 34 about to cross the EMA 62 and Kumo twist took place last week going to $1.17

[K90]

I just bought some more shares and averaged up. I'd like to think I've done enough DD and the upcoming merger is really promising. Especially when you consider that they have to hit $1 before the year end to remain on the NASDAQ.

[24seven]

ADAT nice moves today on average volume. In time I'm considering a position here.

[stocktrademan]

$ADAT recent news/filings

bullish 0.62

## source: finance.yahoo.com

Wed, 09 Dec 2015 11:07:25 GMT ~ Authentidate Announces First Quarter Financial Results

[at noodls] - Proposed Combination with AEON Clinical Laboratories Progresses Berkeley Heights, NJ November 13, 2015 Authentidate Holding Corp. (Nasdaq: ADAT), a provider of secure web-based revenue cycle management ...

read full: http://www.noodls.com/view/1C39638E701FDB4D6CB1C5EFB05FFCDC960F35FC
*********************************************************

Wed, 09 Dec 2015 10:57:14 GMT ~ Authentidate Holding Corp. and AEON Clinical Laboratories Announce Execution of Definitive Merger Agreement

[at noodls] - Berkeley Heights, NJ Gainesville, GA November 19, 2015 Authentidate Holding Corp. (NASDAQ: ADAT) and Peachstate Health Management, LLC d/b/a AEON Clinical Laboratories today announced that they have entered ...

read full: http://www.noodls.com/view/F250C606BA08424E9898DFCCBCEC960928E1843C
*********************************************************

Tue, 08 Dec 2015 18:17:59 GMT ~ AUTHENTIDATE HOLDING CORP Financials


read full: http://finance.yahoo.com/q/is?s=adat
*********************************************************

Tue, 01 Dec 2015 21:17:49 GMT ~ AUTHENTIDATE HOLDING CORP Files SEC form 8-K, Entry into a Material Definitive Agreement


read full: http://biz.yahoo.com/e/151201/adat8-k.html
*********************************************************

Thu, 19 Nov 2015 21:04:43 GMT ~ AUTHENTIDATE HOLDING CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity


read full: http://biz.yahoo.com/e/151119/adat8-k.html
*********************************************************

$ADAT charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$ADAT company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/ADAT/company-info
Ticker: $ADAT
OTC Market Place: Not Available
CIK code: 0000885074
Company name: AuthentiDate Holding Corp.
Company website: http://www.authentidate.com
Incorporated In: DE, USA

Business Description:

$ADAT share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: 42,755,942 a/o Nov 05, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$ADAT extra dd links

Company name: AuthentiDate Holding Corp.
Company website: http://www.authentidate.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ADAT/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ADAT/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ADAT+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ADAT+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ADAT+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ADAT/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ADAT/news - http://finance.yahoo.com/q/h?s=ADAT+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ADAT/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ADAT/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ADAT/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ADAT/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ADAT/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ADAT/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ADAT/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ADAT/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ADAT+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ADAT
DTCC (dtcc.com): http://search2.dtcc.com/?q=AuthentiDate+Holding+Corp.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=AuthentiDate+Holding+Corp.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=AuthentiDate+Holding+Corp.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.authentidate.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.authentidate.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.authentidate.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ADAT/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ADAT
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ADAT/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ADAT/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ADAT/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000885074&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ADAT/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ADAT/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ADAT/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ADAT/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ADAT&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ADAT
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ADAT/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ADAT+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ADAT+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ADAT
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ADAT
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ADAT+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ADAT/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ADAT+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ADAT.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ADAT
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ADAT/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ADAT/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ADAT/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ADAT/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ADAT
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ADAT
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ADAT:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ADAT
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ADAT



$ADAT DD Notes ~ http://www.ddnotesmaker.com/ADAT

[Roy London]

ADAT...merge is done...lets rollll!!!!